These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37337076)

  • 21. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
    Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors.
    Porcaro AB; Orlando R; Panunzio A; Tafuri A; Baielli A; Artoni F; Montanaro F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Veccia A; Boldini M; Treccani LP; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Cerruto MA; Antonelli A
    J Robot Surg; 2024 Mar; 18(1):134. PubMed ID: 38520651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era.
    Truesdale MD; Lee DJ; Cheetham PJ; Hruby GW; Turk AT; Badani KK
    J Endourol; 2010 Jul; 24(7):1055-60. PubMed ID: 20575697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.
    Morizane S; Honda M; Shimizu R; Tsounapi P; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2022 Apr; 27(4):781-789. PubMed ID: 35076818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
    Meijer D; van Leeuwen PJ; Donswijk ML; Boellaard TN; Schoots IG; van der Poel HG; Hendrikse HN; Oprea-Lager DE; Vis AN
    BJU Int; 2022 Jan; 129(1):54-62. PubMed ID: 34028165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.
    Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI
    Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
    Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
    Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection.
    Porcaro AB; Sebben M; Tafuri A; de Luyk N; Corsi P; Processali T; Pirozzi M; Rizzetto R; Amigoni N; Mattevi D; Cerruto MA; Brunelli M; Novella G; De Marco V; Migliorini F; Artibani W
    J Robot Surg; 2019 Feb; 13(1):83-89. PubMed ID: 29737495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.
    Kim DK; Koo KC; Lee KS; Hah YS; Rha KH; Hong SJ; Chung BH
    J Korean Med Sci; 2018 Nov; 33(45):e285. PubMed ID: 30402050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended pelvic lymph node dissection in robot-assisted radical prostatectomy is an independent risk factor for major complications.
    Baas DJH; de Baaij JMS; Sedelaar JPM; Hoekstra RJ; Vrijhof HJEJ; Somford DM; van Basten JA
    J Robot Surg; 2024 Mar; 18(1):140. PubMed ID: 38554195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
    Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
    J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
    Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
    BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
    Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
    Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.